Pharmacology of tamsulosin: Saturation-binding isotherms and competition analysis using cloned α1-adrenergic receptor subtypes

Prostate

Volumn 33, Issue 1, 1997, Pages 55-59

  Richardson, Charlene D ^a   Donatucci, Craig F ^a   Page, Stella O ^a   Wilson, Katrina H ^a   Schwinn, Debra A ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adrenergic antagonists; Adrenergic receptor; Adrenoceptor; Benign prostatic hyperplasia; BPH; Prostate

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; TAMSULOSIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; DRUG EFFICACY; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RAT; RECEPTOR BINDING;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BINDING, COMPETITIVE; CELL LINE; CLONING, MOLECULAR; FIBROBLASTS; PHENETHYLAMINES; RATS; RECEPTORS, ADRENERGIC, ALPHA; SULFONAMIDES; TETRALONES;

EID: 0030752642     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970915)33:1<55::AID-PROS9>3.0.CO;2-8     Document Type: Article

References (36)

1. 1-adrenoceptor subtypes in the human prostate. Br J Urol 1994;74:585-589.
2. Hieble JP, Caine M, Zalaznik E: In vitro characterization of the α-adrenoceptors in human prostate. Eur J Pharmacol 1985;107: 111-117.
3. Yamaguchi O, Shiraiwa Y, Kobayashi M, Yodota T, Ohinata M, Aoki H, Tsuzuki T, Ohori M: Clinical evaluation of effects of prazosin in patients with benign prostatic obstruction. A double-blind, multi-institutional, paraprost-controlled study. Urol Int [Suppl] 1990;45:40-46.
4. 1 adrenoceptors and area density of smooth muscle in the human, canine, and rat prostates. J Pharmacol Exp Ther 1994;270:722-727.
5. 1-adrenoceptors: Consensus update. Pharmacol Rev 1995;47:267-270.
6. 1-adrenoceptor subtypes in the human prostate: Functional and binding studies. Br J Urol 1994;74:572-577.
7. 1-adrenoceptor subtypes in rat heart: A binding study. Br J Pharmacol 1995;114:1026-1030.
8. Lepor H: Role of α-adrenergic blockers in the treatment of benign prostatic hyperplasia. Prostate [Suppl] 1990;3:75-84.
9. 1-adrenoceptor antagonists to prostatic α-adrenoceptors in benign prostatic hypertrophy. Life Sci 1992;50:127-135.
10. 1-adrenergic receptor. J Biol Chem 1990;265:8183-8189.
11. 1-adrenergic receptor. Proc Natl Acad Sci USA 1988;85:7159-7163.
12. 1A-adrenergic receptor. J Biol Chem 1991;266:6365-6369.
13. 1-adrenoceptors in vascular smooth muscle. Mol Pharmacol 1994;46:30-40.
14. Cepko CL, Roberts BE, Mulligan RC: Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell 1984;37:1053-1062.
15. Cullen BE: Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol 1987;152:684-704.
16. 1-adrenergic receptors: Sequence corrections and direct comparison with other species homologues. J Pharmacol Exp Ther 1995;272:134-142.
17. 1-adrenoceptor radioligand. J Pharmacol Exp Ther 1992;263:201-206.
18. Caine M, Raz S, Zeigler M: Adrenergic and cholinergic receptors in the human prostate, prostate capsule and bladder neck. Br J Urol 1975;47:193-202.
19. Raz S, Zeigler M, Caine M: Pharmacological receptors in the prostate. Br J Urol 1973;27:663-667.
20. Chapple CR, Aubry ML, James S, Greengrass PM, Burnstock G, Turner-Warwick RT, Milroy EJG, Davey MJ: Characterisation of human prostatic adrenoceptors using pharmacology receptor binding and localisation. Br J Urol 1989;63:487-496.
21. 1-adrenoceptor mediated prostatic smooth muscle contraction. Urol Res 1994;22:143-146.
22. 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy. Eur J Pharmacol 1995;288:201-207.
23. 1c subtype. Mol Pharmacol 1994;45:703-708.
24. 1-adrenoceptor subtypes in the rabbit prostate. J Auton Pharmacol 1995;15:271-278.
25. 1-adrenoceptor subtypes in prostate and prostatic urethra of rat, rabbit, dog and man. Eur J Pharmacol 1993;249:307-315.
26. 1-adrenoceptor antagonist binding in human prostate and aorta. Clin Exp Pharmacol Physiol 1994;21:405-411.
27. 1-antagonists. Life Sci 1994;54:1845-1854.
28. 1 adrenergic receptor subtypes in human prostate. J Urol 1993;150:546-551.
29. 1-adrenoceptor subtypes present in the human prostate. Life Sci 1994;54:1595-1605.
30. 1c-adrenoceptor splice variants. FEBS Lett 1995;363:256-260.
31. 1-adrenoceptors in human prostate: Implications for adrenoceptor classification. Mol Pharmacol 1996;49:209-215.
32. 1a-adrenoceptor? Proceedings of the British Pharmacological Society Meeting. Br J Pharmacol 1996;118 Suppl:29p.
33. Saussy DL, Goetz AS, Queen KL, King HK, Lutz MW, Rimele TJ: Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: Further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype. J Pharmacol Exp Ther 1996;278:136-144.
34. 1c-adrenoceptor antagonist: A randomized, controlled trial in patients with benign prostatic "obstruction" (symptomatic BPH). Br J Urol 1995;76:325-556.
35. 1a-adrenoceptor antagonist: A meta-analysis of two randomized placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). Eur Urol 1996;29:155-167.
36. 1a-adrenoceptor antagonist: Analysis of a multinational, multicentre, open-label study assessing the long-term efficacy and safety in patients with benign prostatic obstruction (symptomatic BPH). Eur Urol 1996;29:145-154.